JPS604802B2 - 制癌剤 - Google Patents

制癌剤

Info

Publication number
JPS604802B2
JPS604802B2 JP51107520A JP10752076A JPS604802B2 JP S604802 B2 JPS604802 B2 JP S604802B2 JP 51107520 A JP51107520 A JP 51107520A JP 10752076 A JP10752076 A JP 10752076A JP S604802 B2 JPS604802 B2 JP S604802B2
Authority
JP
Japan
Prior art keywords
anticancer
carbamoyl
injection
compound
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP51107520A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5332124A (en
Inventor
登 吉田
孝雄 清原
重男 荻野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Priority to JP51107520A priority Critical patent/JPS604802B2/ja
Priority to AU28619/77A priority patent/AU509455B2/en
Priority to FR7727134A priority patent/FR2363329A1/fr
Priority to DE19772740281 priority patent/DE2740281A1/de
Priority to NL7709853A priority patent/NL7709853A/xx
Priority to CA286,281A priority patent/CA1078736A/fr
Publication of JPS5332124A publication Critical patent/JPS5332124A/ja
Priority to US05/918,074 priority patent/US4181731A/en
Publication of JPS604802B2 publication Critical patent/JPS604802B2/ja
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP51107520A 1976-09-07 1976-09-07 制癌剤 Expired JPS604802B2 (ja)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP51107520A JPS604802B2 (ja) 1976-09-07 1976-09-07 制癌剤
AU28619/77A AU509455B2 (en) 1976-09-07 1977-09-07 4-carbamoy-5-hydroxyimdazole to treat cancer
FR7727134A FR2363329A1 (fr) 1976-09-07 1977-09-07 Compositions renfermant du 4-carbamoyl-5-hydroxyimidazole, utiles comme agent pour le traitement de cancers, de rhumatismes et de nephrites
DE19772740281 DE2740281A1 (de) 1976-09-07 1977-09-07 Verwendung von 4-carbamoyl-5-hydroxyimidazol bei der behandlung von krebs, rheumatismus und nephritis
NL7709853A NL7709853A (nl) 1976-09-07 1977-09-07 Nieuwe farmaceutische toepassing van 4-carbamoyl- -5-hydroxyimidazol.
CA286,281A CA1078736A (fr) 1976-09-07 1977-09-07 Usages therapeutiques du 4-carbamoyl-5-hydroxyimidazole
US05/918,074 US4181731A (en) 1976-09-07 1978-06-22 Novel therapeutic application of 4-carbamoyl-5-hydroxyimidazole

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP51107520A JPS604802B2 (ja) 1976-09-07 1976-09-07 制癌剤

Publications (2)

Publication Number Publication Date
JPS5332124A JPS5332124A (en) 1978-03-27
JPS604802B2 true JPS604802B2 (ja) 1985-02-06

Family

ID=14461270

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51107520A Expired JPS604802B2 (ja) 1976-09-07 1976-09-07 制癌剤

Country Status (6)

Country Link
JP (1) JPS604802B2 (fr)
AU (1) AU509455B2 (fr)
CA (1) CA1078736A (fr)
DE (1) DE2740281A1 (fr)
FR (1) FR2363329A1 (fr)
NL (1) NL7709853A (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU507066B1 (en) * 1977-09-06 1980-01-31 Sumitomo Chemical Company, Limited 2-Substituted-5-Hydroxy-1h-Imidazole 4-Carbozamide Derivatives
JPS5495568A (en) * 1978-01-06 1979-07-28 Sumitomo Chem Co Ltd Novel imidazoleacetic acid derivative
AU530916B2 (en) * 1979-08-08 1983-08-04 Sumitomo Chemical Company, Limited 4-carbamoyl imidazolium-5-olate derivatives
JPS5780317A (en) * 1980-11-05 1982-05-19 Sumitomo Chem Co Ltd Preparation of pharmaceutical composition for injection
DE3176849D1 (en) * 1980-11-05 1988-09-29 Sumitomo Chemical Co Pharmaceutical composition comprising 4-carbamoyl-imidazolium-5-olate
US4464531A (en) * 1981-04-20 1984-08-07 Sumitomo Chemical Company, Limited 4-Carbamoylimidazolium-5-olate derivatives
JPS6089418A (ja) * 1983-10-20 1985-05-20 Sumitomo Chem Co Ltd 徐放性制癌剤
JPS60193997A (ja) * 1984-03-14 1985-10-02 Sumitomo Chem Co Ltd 新規シアノイミダゾ−ルリボヌクレオシド誘導体およびその製造法
ATE250481T1 (de) * 1998-11-13 2003-10-15 Elpatronic Ag Verfahren zum schweissen von rohren sowie einrichtung zu dessen durchführung
JP5266010B2 (ja) 2007-09-14 2013-08-21 富士フイルム株式会社 ４−カルバモイル−５−ヒドロキシ−イミダゾール誘導体のスルホン酸塩化合物
EP2946763A4 (fr) 2013-01-15 2016-07-27 Fujifilm Corp Emballage pour préparation solide comprenant du 5-hydroxy-1h-imidazole-4-carboxamide ou un sel ou hydrate de celui-ci
CN104271134B (zh) 2013-01-15 2016-06-29 富士胶片株式会社 含有5-羟基-1h-咪唑-4-甲酰胺的片剂
EP2947069B1 (fr) 2013-01-15 2017-11-22 FUJIFILM Corporation Sulfate de 5-hydroxy-1h-imidazole-4-carboxamide
WO2015105174A1 (fr) 2014-01-10 2015-07-16 富士フイルム株式会社 Procédé de prédiction et dispositif de prédiction de dose efficace/sensibilité de 5-hydroxy-1h-imidazole-4-carboxamide, procédé de mesure de quantité de monophosphate de xanthosine, et agent de traitement et procédé de traitement de syndrome myélodysplasique

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52101855A (en) * 1976-02-21 1977-08-26 Toyo Seisakusho Kk Air moistener

Also Published As

Publication number Publication date
AU2861977A (en) 1979-03-15
FR2363329A1 (fr) 1978-03-31
DE2740281A1 (de) 1978-03-09
CA1078736A (fr) 1980-06-03
JPS5332124A (en) 1978-03-27
AU509455B2 (en) 1980-05-15
FR2363329B1 (fr) 1981-01-23
NL7709853A (nl) 1978-03-09

Similar Documents

Publication Publication Date Title
TW420607B (en) Rapamycin pharmaceutical compositions for oral administration
TW461812B (en) Rapamycin-containing pharmaceutical composition for oral administration
KR100221689B1 (ko) 항말라리아조성물
JPS604802B2 (ja) 制癌剤
CZ301771B6 (cs) Farmaceutický prostredek ve forme suchého granulátu obsahující mofetil mykofenolát nebo kyselinu mykofenolovou a zpusob jeho prípravy
EP0427246A2 (fr) Compositions pharmaceutiques contenant comme principe actif des acides carboxyliques soufrés ainsi que leur utilisation dans la lutte contre les rétrovirus
WO1992021345A1 (fr) Composition, methode et trousse pour le traitement des tumeurs par stimulation de l'activite antitumorale
US20140371242A1 (en) Azathioprine Oral Suspensions and Methods of Use
JP2002501015A (ja) リーシュマニア症の治療における経口投与のためのミルテフォシンを含有する固形医薬品
CN111956652A (zh) 一种西地那非口腔膜剂药物组合及其制备方法
JP2002512979A (ja) アバカビール、ラミブジンおよびジドブジンを含んでなる均質な医薬組成物
PL190505B1 (pl) Kompozycja farmaceutyczna i sposób jej wytwarzania
EP0190851B1 (fr) Composition anti-inflammatoire
US3144387A (en) Anti-inflammatory compositions
KR0133555B1 (ko) 5-플루오로우라실계 화합물에 기인한 염증의 발생을 억제할 수 있는 비-주사제 형태의 항암조성물
WO1992001448A1 (fr) Remede contre l'apnee du sommeil
CN104302651B (zh) 锗的配位化合物、其生产方法和药物
CN108186631B (zh) 一种药物组合物及其制备方法和用途
WO2003015807A1 (fr) Agents supprimant les effets indesirables et/ou stimulateurs de l'effet hypoglycemique destines aux derives de thiazolidine
US4131678A (en) Urapidil/furosemide compounds, compositions and use
CN100594933C (zh) 抗肥胖剂和健康食品
KR100367877B1 (ko) 구연산칼륨을 주제로 한 요로결석 치료제중 분말 및 미립제형 의 제조방법
JPH06506706A (ja) ベンゾフルメトールを含有する抗マラリア性の相乗作用組成物
EP0652223A1 (fr) Polymère de l'acide 3-oxygermylpropiomique
CA2167841A1 (fr) Methode d'inhibition de la production de virus d'immunodeficience humaine a l'aide de derives de substitution d'azaspiranes